PositoAI/ US/ vTv Therapeutics Inc.

vTv Therapeutics Inc.

NasdaqCM: VTVT · Healthcare

Positivity Index

#2,262 / 6,775

Global

#643 / 4,000

United States

Positivity Score

21,746

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

vTv Therapeutics Inc. — Overview & Financial Snapshot

vTv Therapeutics Inc. (NasdaqCM: VTVT) is a Healthcare company, ranked #2,262 of 6,775 companies globally and #643 of 4,000 in United States on PositoAI, with a Positivity Score of 21,746. Its market capitalisation is ₹1,013.65 Cr ($107.39M), P/E ratio is -37.7 and P/B ratio is 1.37. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP399), an orally administered small molecule and liver-selective glucokinase activator that is in Phase III clinical trial to treat type 1 diabetes. The company is also investing a range of molecules across various indications for chronic diseases. It has a license agreement Newsoara Biopharma Co., Ltd. to develop and commercialize phosphodiesterase type 4 inhibitors program. vTv Therapeutics Inc. was incorporated in 2015 and is headquartered in High Point, North Carolina.

P/B Ratio 1.37

P/E Ratio -37.7

D/E Ratio 0.00

ROE -15.80%

Owes vs Owns ? 0.10× Low $0.10 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-67.96$-0.72

Forward EPS ₹-413.57$-4.38

Beta 0.21

Market Cap ₹1,013.65 Cr$107.39M

What these numbers mean →

What does vTv Therapeutics Inc. do?

What is vTv Therapeutics Inc.'s P/E and P/B ratio?

vTv Therapeutics Inc. has a P/E ratio of -37.7 and a P/B ratio of 1.37.

What is vTv Therapeutics Inc.'s debt-to-equity ratio?

vTv Therapeutics Inc. has a debt-to-equity ratio of 0.00.

How much does vTv Therapeutics Inc. owe compared with what it owns?

vTv Therapeutics Inc. owes $0.10 for every $1 it owns (balance sheet Jun 2026), which is low.

What is vTv Therapeutics Inc.'s Positivity rank?

vTv Therapeutics Inc. is ranked #2,262 of 6,775 companies globally and #643 of 4,000 in United States on PositoAI, with a Positivity Score of 21,746.

Does vTv Therapeutics Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for vTv Therapeutics Inc..

Where can I read the latest news about vTv Therapeutics Inc.?

Recent headlines about vTv Therapeutics Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does vTv Therapeutics Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of vTv Therapeutics Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.